Feedback

Browsing by L


Use an asterisk (*) for partial word searches (e.g. pemph*)

125 results found.

1.
Ordering Recommendation:   Therapeutic drug monitoring.
2.
3.
Ordering Recommendation:   Do not use to detect myocardial injury. Cardiac troponins [troponin I (0090613)or troponin T (0098803)] are the recommended tests for diagnosis and management of acute coronary syndrome. In rare cases, this test may be used to evaluate elevated lactate dehydrogenase associated with non-cardiac muscle injury.
4.
5.
Ordering Recommendation:   When considering pyruvic acid testing, this is the preferred test. This test reports concentrations for lactate, pyruvate, and the L:P ratio on the same specimen.
6.
7.
8.
9.
Ordering Recommendation:   Do not use to diagnose inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS); may be used for monitoring IBD activity.
10.
11.
Ordering Recommendation:   Quantify and determine clonality of free lambda light chains (Bence Jones protein) in urine.
12.
13.
Ordering Recommendation:   Preferred fetal lung maturity test.
14.
15.
16.
17.
18.
19.
Ordering Recommendation:   May be useful in determining past exposure to lead. Not recommended for the routine assessment of lead toxicity.
20.
Ordering Recommendation:   Detect exposure to lead primarily in pediatric patients.
21.
Ordering Recommendation:   Detect and confirm exposure to lead.
22.
Ordering Recommendation:   Detect and confirm exposure to lead; testing consistent with OSHA guidelines.
23.
Ordering Recommendation:   Not recommended for the routine assessment of lead toxicity.
24.
Ordering Recommendation:   Detect acute exposure to lead; monitor chelation therapy.
25.
26.
Ordering Recommendation:   Preferred fetal lung maturity test is Lamellar Body Counts (0080940). Lecithin-sphigomyelin ratio may be useful adjucating immature LBC or PG. Results require>24 hrs unless performed at a local laboratory.
27.
Ordering Recommendation:   Intended for therapeutic drug monitoring and evaluating full elimination of the drug (eg, toxicity, pregnancy).
28.
29.
30.
31.
32.
33.
34.
35.
36.
Ordering Recommendation:   This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.
37.
Ordering Recommendation:   Diagnostic testing for Legius syndrome. Predictive testing for Legius syndrome.
38.
Ordering Recommendation:   Preferred test for confirming diagnosis of LS in symptomatic individuals who test negative for NF1 gene mutations.
39.
40.
41.
42.
43.
44.
45.
Ordering Recommendation:   Aids in diagnosis of()Leucine-rich Glioma Inactivated 1 Protein (LGI1) Antibody disorders associated with limbic encephalitis, hyponatremia, myoclonic movements. Disorders are rarely associated with tumors.()Contactin Associated Protein 2 (CASPR2) Antibody disorders associated with acquired neuromyotonia, limbic encephalitis, painful neuropathy, and Morvan syndrome.Use to manage antibody-positive (LGI1 or CASPR2) individual following immunotherapy and/or plasmapheresis.
46.
Ordering Recommendation:   Aids in diagnosis of Leucine-rich Glioma Inactivated 1 Protein (LGI1) antibody disorders associated with limbic encephalitis, hyponatremia, myoclonic movements. Disorders are rarely associated with tumors. Use to manage antibody-positive (LGI1) individual following immunotherapy and/or plasmapheresis.
47.
Ordering Recommendation:   Aids in the diagnosis of hematopoietic neoplasms.
48.
Ordering Recommendation:   Aids in the diagnosis of type I and II leukocyte adhesion deficiency. Panel measures CD11b, CD15, and CD18 on neutrophils.
49.
50.
51.
52.
Ordering Recommendation:   Appropriate initial test for Li-Fraumeni syndrome (LFS).
53.
Ordering Recommendation:   Most comprehensive test for Li-Fraumeni syndrome (LFS).
54.
Ordering Recommendation:   This is a second tier test and REQUIRES PERMISSION from ARUPs Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the combined sequencing and deletion/duplication test.
55.
56.
57.
58.
59.
60.
61.
Ordering Recommendation:   Use to assess cardiovascular disease risk and guide therapy.
62.
Ordering Recommendation:   Use to assess cardiovascular disease risk and guide therapy.
63.
Ordering Recommendation:   Standard fasting lipid panel (0020421) is preferred for most individuals. Not recommended for cardiovascular disease risk assessment in most individuals.
64.
65.
Ordering Recommendation:   Not recommended for cardiovascular risk assessment in asymptomatic adults. May aid in CVD risk stratification in specific populations.
66.
67.
68.
Ordering Recommendation:   Not recommended for cardiovascular disease risk assessment in asymptomatic adults. May aid in CVD risk stratification in specific populations.
69.
70.
71.
72.
73.
74.
75.
Ordering Recommendation:   Use to evaluate for autoimmune hepatitis of unknown etiology.
76.
Ordering Recommendation:   Noninvasive, serum surrogate marker test for assessment of liver fibrosis in patients with chronic viral hepatitis.
77.
78.
79.
Ordering Recommendation:   Confirm suspected laminopathy caused by LMNA deletions/duplications including Emery-Dreifuss muscular dystrophy type 2, Limb-girdle muscular dystrophy 1B or dilated cardiomyopathy.
80.
Ordering Recommendation:   Confirm suspected laminopathy caused by LMNA mutations including Hutchinson-Gilford progreria, Emery-Dreifuss muscular dystrophy type 2, Limb-girdle muscular dystrophy 1B, Charcot-Marie-Tooth 2B1, Dunnigan type familial partial lipodystrophy, mandibulo-acral dysplasia, atypical Werner syndrome, restrictive dermopathy or dilated cardiomyopathy.
81.
Ordering Recommendation:   Confirm clinical diagnosis of Loeys-Dietz Syndrome.
82.
Ordering Recommendation:   Refer to Additional Technical Information document.
83.
84.
85.
86.
87.
Ordering Recommendation:   May be useful in screening a select group of individuals 40-75 years who are at high risk for lung cancer (eg, long-term smokers).
88.
Ordering Recommendation:   Screening panel to determine eligibility for TKIs. EGFR, ALK, and ROS1 genes tested; EGFR by Pyrosequencing and ALK and ROS1 translocations by IHC. To include KRAS by PCR, refer to Lung Cancer Panel with KRAS (2008895).
89.
Ordering Recommendation:   Screening panel to determine eligibility for TKIs. EGFR, KRAS, ALK, and ROS1 genes tested; EGFR and KRAS by Pyrosequencing and ALK and ROS1 translocations by IHC.
90.
Ordering Recommendation:   Most comprehensive screening panel for determining eligibility for TKI therapy. Detects mutations in ALK, AKT1, BRAF, EGFR, ERBB2, ERBB4, KRAS, NRAS, and PIK3CA genes, and ALK, ROS, and RET translocations.
91.
Ordering Recommendation:   Use for unexplained prolonged PTT or for patients with a significant probability of having antiphospholipid syndrome (APS). For APS, order with anticardiolipin (aCL) (0099344) and anti-beta-2-glycoprotein 1 (anti-beta[2]GP1) (0050321) antibody IgG and IgM assays.
92.
93.
94.
Ordering Recommendation:   Test is intended for patients 2 weeks-6 years of age. For patients 7 years and older, order Luteinizing Hormone, Serum (0070093).
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
Ordering Recommendation:   Aids in clinical management of HIV-positive individuals.
105.
Ordering Recommendation:   Absolute CD4 count is sufficient for routine HIV monitoring.
106.
Ordering Recommendation:   Absolute CD4 count is sufficient for routine HIV monitoring.
107.
Ordering Recommendation:   Absolute CD4 count is sufficient for routine HIV monitoring.
108.
109.
110.
Ordering Recommendation:   Useful for assessing primary T-cell immunodeficiency disorders.
111.
Ordering Recommendation:   Acceptable lymphocyte subset panel for the investigation of primary immunodeficiency disorders.
112.
113.
Ordering Recommendation:   Intended for TRANSPLANT patients only.
114.
Ordering Recommendation:   Identify lymphocytic choriomeningitis virus as pathogen for meningitis.
115.
116.
117.
118.
119.
120.
Ordering Recommendation:   Aid in diagnosis/prognostication for aggressive morphology and unclear features between Burkitt lymphoma and diffiuse large B-cell lymphoma (DLBCL).
121.
Ordering Recommendation:   Evaluation of patients with a clinical presentation suggestive of lysosomal acid lipase deficiency
122.
123.
124.
125.